We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

129 hedge funds and large institutions have $1.4B invested in IVERIC bio, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 10

30% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 40

11% more funds holding

Funds holding: 116 → 129 (+13)

3% more capital invested

Capital invested by funds: $1.36B → $1.4B (+$46.7M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

20% less call options, than puts

Call options by funds: $5.69M | Put options by funds: $7.13M

Holders
129
Holders Change
+13
Holders Change %
+11.21%
% of All Funds
3.44%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
23
Increased
52
Reduced
40
Closed
10
Calls
$5.69M
Puts
$7.13M
Net Calls
-$1.44M
Net Calls Change
+$473K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$41.9M
2
Renaissance Technologies
Renaissance Technologies
New York
+$19.4M
3
Morgan Stanley
Morgan Stanley
New York
+$10.4M
4
Franklin Resources
Franklin Resources
California
+$7.93M
5
AP
AHL Partners
United Kingdom
+$5.87M

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$51.5M
2
SHI
SV Health Investors
Massachusetts
-$29.5M
3
PA
Perceptive Advisors
New York
-$19.3M
4
RCM
RA Capital Management
Massachusetts
-$13.9M
5
Goldman Sachs
Goldman Sachs
New York
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$5M +$4.67M +89,966 +517%
WHI
27
William Harris Investors
Illinois
$4.94M +$3.95M +76,064 +253%
OM
28
Opaleye Management
Massachusetts
$4.89M +$260K +5,000 +5%
MAA
29
Managed Account Advisors
New Jersey
$4.75M +$339K +6,537 +7%
TCIM
30
TIAA CREF Investment Management
New York
$4.73M +$298K +5,744 +6%
Axa
31
Axa
France
$4.46M +$351K +6,763 +8%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$4.39M -$252K -4,860 -5%
Two Sigma Investments
33
Two Sigma Investments
New York
$4.37M +$4.28M +82,433 +718%
Barclays
34
Barclays
United Kingdom
$4.34M -$209K -4,026 -4%
American Century Companies
35
American Century Companies
Missouri
$3.96M -$291K -5,600 -6%
Invesco
36
Invesco
Georgia
$3.94M +$147K +2,840 +3%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$3.91M +$107K +2,066 +3%
Millennium Management
38
Millennium Management
New York
$3.85M -$1.3M -25,025 -23%
IAS
39
IMA Advisory Services
Colorado
$3.16M +$153K +2,940 +5%
HCM
40
Highbridge Capital Management
New York
$2.97M +$2.8M +53,945 +545%
Wellington Management Group
41
Wellington Management Group
Massachusetts
$2.91M +$161K +3,100 +5%
NI
42
Numeric Investors
Massachusetts
$2.91M +$3.24M +62,500 New
EI
43
EAM Investors
California
$2.71M +$5.04K +97 +0.2%
AllianceBernstein
44
AllianceBernstein
Tennessee
$2.39M -$119K -2,300 -4%
OMC
45
Overbrook Management Corp
New York
$2.33M +$2.6M +50,000 New
Charles Schwab
46
Charles Schwab
California
$1.94M +$596K +11,476 +38%
JP Morgan Chase
47
JP Morgan Chase
New York
$1.83M +$1.4M +26,891 +216%
BIM
48
BlackRock Investment Management
Delaware
$1.77M +$34.4K +663 +2%
AP
49
AlpInvest Partners
Netherlands
$1.75M -$1.46M -28,136 -43%
CS
50
Credit Suisse
Switzerland
$1.66M -$154K -2,972 -8%
1
2
3 4 5

ISEE Hedge Fund Activity: Q1 2015 in Review

129 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2015, worth a combined $1.4B — up 3.4% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ISEE positions and 10 closed out — a net gain of 13 holders — while 52 added to existing stakes and 40 trimmed.

The largest buyer was OrbiMed, adding an estimated $41.9M. The largest seller was Novo Holdings A/S, cutting an estimated $51.5M.

  • 129 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2015, up from 116 in Q4 2014.
  • Funds reported $1.4B of IVERIC bio, Inc. Common Stock stock for Q1 2015, up 3.4% quarter-over-quarter.
  • 23 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2015 and 10 closed out, a net change of +13 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q1 2015 was OrbiMed, an estimated $41.9M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q1 2015 was Novo Holdings A/S, an estimated $51.5M sold.

Based on aggregated 13F filings for Q1 2015.